Although licensed cannabis producers have taken most of the headlines this year, there are more places to invest and other attractive sub-industries within the Canadian cannabis industry.
INDIVA Limited (TSX-V:NDVA) is pleased to announce it has closed its previously announced acquisition of 100% of the issued and outstanding securities of Indiva Corporation ("Indiva") by way of a "three-cornered" statutory amalgamation of Indiva and a wholly-owned subsidiary of the Company (the "Acquisition").
The legal cannabis sector is the fastest growing industry in the world and we expect 2018 to a major year for the sector.
Canada has been leading the global cannabis industry and the country is capitalizing on a global opportunity. Over the next year, we expect to see Canadian cannabis producers expand their reach and enter new international markets.
2017 has been a great year for cannabis investors and expect 2018 to be even more significant.
From Germany distributing medical marijuana licenses to Canada’s recreational marijuana market opening, there is a lot for investors to look forward to.
The cannabis sector recorded mixed price movements yesterday and we are monitoring how the sector closes out the week.
There have been several significant announcements over the last week and today, we highlighted 5 company developments that investors should be aware of.
CanniMed Trades Higher on PharmaChoice Deal
Canadian cannabis stocks traded higher yesterday after Aphria announced an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
We are favorable on this development and expect to see more agreements like this announced in 2018. Today, we have highlighted 7 company developments that we think investors need to be aware of.
TSX Defers Acceptance of CanniMed’s Plan
The cannabis sector has been under pressure and many investors are closely watching how the market moves from here.
The recent weakness has been significant and it has caused momentum to revert back from overbought levels. We will keep an eye on this metric and expect to see the market come off its recent lows.
Drawing on years of innovation and research, and a deep understanding of the potential of the cannabis plant, Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, today launched The Edison Project.